Insight Molecular Diagnostics Inc. (IMDX)
$4.13-$0.16 (-3.73%) Today
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 86,217 | |
| Tax withholding / forfeiture | 3 | 27,500 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
26 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lou Silverman - Director | Tax withholding / forfeiture | Common Stock, no par value | 7,700 | $5.69 | $44K | |
| Andrew J. Last - Director | Tax withholding / forfeiture | Common Stock, no par value | 7,700 | $5.69 | $44K | |
| Andrew Arno - Director | Tax withholding / forfeiture | Common Stock, no par value | 12,100 | $5.69 | $69K | |
| Lou Silverman - Director | Grant or award | Common Stock, no par value | 26,943 | $0.00 | - | |
| Andrew J. Last - Director | Grant or award | Common Stock, no par value | 26,943 | $0.00 | - | |
| Andrew Arno - Director | Grant or award | Common Stock, no par value | 32,331 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 280,381 | $3.50 | $982K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 38,880 | $3.53 | $137K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 250,923 | $3.64 | $913K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 102,057 | $3.45 | $352K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 40,114 | $3.57 | $143K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 40,690 | $3.88 | $158K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| Andrea S. James - Officer | Option exercise | Common Stock | 28,302 | - | - | |
| Andrea S. James - Officer | Tax withholding / forfeiture | Common Stock | 11,298 | $4.11 | $46K | |
| Andrea S. James - Officer | Option exercise | Restricted Stock Units | 28,302 | $0.00 | - | |
| James Yang Liu - Officer | Option exercise | Common Stock | 6,289 | - | - | |
| James Yang Liu - Officer | Tax withholding / forfeiture | Common Stock | 2,578 | $4.11 | $11K | |
| James Yang Liu - Officer | Option exercise | Restricted Stock Units | 6,289 | $0.00 | - | |
| Josh Riggs - Officer | Option exercise | Common Stock | 47,170 | - | - | |
| Josh Riggs - Officer | Tax withholding / forfeiture | Common Stock | 12,310 | $4.11 | $51K | |
| Josh Riggs - Officer | Option exercise | Restricted Stock Units | 47,170 | $0.00 | - | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 521,739 | $5.75 | $3.00M | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - | |
| Andrea S. James - Officer | Option exercise | Common Stock | 50,000 | $0.00 | - | |
| Andrea S. James - Officer | Tax withholding / forfeiture | Common Stock | 12,175 | $6.01 | $73K | |
| Andrea S. James - Officer | Option exercise | Restricted Stock Units | 50,000 | $0.00 | - | |
| Andrea S. James - Officer | Derivative | Restricted Stock Units | 50,000 | $0.00 | - | |
| Andrea S. James - Officer | Option exercise | Common Stock | 50,000 | $0.00 | - | |
| Andrea S. James - Officer | Grant or award | Option to Purchase Common Stock | 235,000 | $0.00 | - | |
| Josh Riggs - Officer | Grant or award | Option to Purchase Common Stock | 400,000 | $0.00 | - | |
| James Yang Liu - Officer | Grant or award | Option to Purchase Common Stock | 18,000 | $0.00 | - | |
| Lou Silverman - Director | Grant or award | Common Stock, no par value | 35,000 | $0.00 | - | |
| Andrew J. Last - Director | Grant or award | Common Stock, no par value | 35,000 | $0.00 | - | |
| Andrew Arno - Director | Grant or award | Common Stock, no par value | 55,000 | $0.00 | - | |
| Patrick W. Smith - 10% Owner | Open-market purchase | Common Stock, no par value | 90,219 | $2.13 | $192K | |
| Andrew Arno - Director | Open-market purchase | Common Stock, no par value | 12,500 | $2.11 | $26K | |
| Andrea S. James - Officer | Open-market purchase | Common Stock, no par value | 20,000 | $2.29 | $46K | |
| Andrea S. James - Officer | Grant or award | Options to Purchase Common Stock | 200,000 | $0.00 | - | |
| Andrea S. James - Officer | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Andrea S. James - Officer | Open-market purchase | Common Stock, no par value | 33,670 | $2.97 | $100K | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 1,315,339 | $2.95 | $3.88M | |
| BROADWOOD PARTNERS, L.P. - 10% Owner | Open-market purchase | Common Stock, no par value | 0 | $0.00 | - |
Insight Molecular Diagnostics Inc. (IMDX) had 6 insider filings in the last 90 days, with the most recent on 2026-07-07. The full record for IMDX runs to 26 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IMDX were filed in the last 90 days. 20 purchases are on record for this company.
No insider sales of IMDX were filed in the last 90 days.
This page tracks IMDX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IMDX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
